Skip to main content
IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
656.73
-3.98 (-0.60%)
At close: Feb 27, 2026, 4:00 PM EST
654.50
-2.23 (-0.34%)
After-hours: Feb 27, 2026, 5:20 PM EST

IDEXX Laboratories Revenue

In the year 2025, IDEXX Laboratories had annual revenue of $4.30B with 10.42% growth. IDEXX Laboratories had revenue of $1.09B in the quarter ending December 31, 2025, with 14.28% growth.

Revenue (ttm)
$4.30B
Revenue Growth
+10.42%
P/S Ratio
12.15
Revenue / Employee
$391,246
Employees
11,000
Market Cap
52.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.30B406.20M10.42%
Dec 31, 20243.90B236.55M6.46%
Dec 31, 20233.66B293.63M8.72%
Dec 31, 20223.37B151.96M4.73%
Dec 31, 20213.22B508.71M18.79%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Thermo Fisher Scientific 44.56B
Danaher 24.57B
IQVIA Holdings 16.31B
Labcorp Holdings 13.95B
Quest Diagnostics 11.04B
Agilent Technologies 7.07B
Illumina 4.34B
Mettler-Toledo International 4.03B
Revenue Rankings

IDXX News

More News